Haak-Frendscho Mary 4
4 · Surrozen, Inc./DE · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Surrozen (SRZN) Director Mary Haak‑Frendscho Receives Award of 5,550 Shares
What Happened
- Director Mary Haak‑Frendscho received a derivative award covering 5,550 shares on 2026-05-13. The filing shows $0.00 paid at grant (typical for option/award grants reported as derivative instruments). This is a grant of equity compensation to a director rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-05-13; Form 4 filed: 2026-05-14 (timely; Form 4 due within two business days)
- Transaction type/code: A — Grant/award (derivative)
- Shares/units granted: 5,550 (reported at $0.00 cash paid)
- Shares owned after transaction: Not disclosed in the provided excerpt
- Footnote: F1 — The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director
- Filing timeliness: Timely (no late filing flag in provided data)
Context
- This is a standard director equity grant (compensation), not a purchase or sale in the market. As a derivative award, the grant gives rights to future shares subject to vesting and exercisability; it does not represent an immediate sale or acquisition of common stock. Such awards are common for director compensation and do not by themselves indicate the director's view on the stock.
Insider Transaction Report
Form 4
Haak-Frendscho Mary
Director
Transactions
- Award
Director Stock Option (right to buy)
[F1]2026-05-13+5,550→ 5,550 totalExercise: $30.14From: 2027-05-13Exp: 2036-05-12→ Common Stock (5,550 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.
Signature
/s/ Charles Williams, Attorney-in-Fact for Mary Haak-Frendscho|2026-05-14